'Heart Walkers' Raise $1.2M For Cardiovascular Research
Over 20,000 people gathered at Ford Field for the American Heart Association's annual Heart Walk.
Watch CBS News
Over 20,000 people gathered at Ford Field for the American Heart Association's annual Heart Walk.
A shortage in supply of the active ingredient used to make Ridalin and Adderall is causing some great concern for local doctors.
Thousands of dead walleye have been washing up on beaches between Toledo and Port Clinton in recent weeks and wildlife researchers want to know why.
My dog Nala stops by on this week's "Street Beat" to show the importance of companionship between animals and seniors. We also talk about problems that arise as we grow older.
Researchers are reporting an alarming combination: bedbugs carrying "superbug'' germs.
Detroit Community Health Connection clinic received ownership of building on MLK Blvd. from DMC and Vanguard.
A landmark study by scientists at Wayne State University has revealed a new way to diagnose and distinguish children with depression.
Do your fingers hold a clue about Lou Gehrig's disease? Possibly.
An accountant working for Munson Healthcare in Traverse City is accused of embezzling more than a million dollars from the healthcare provider.
While many people will celebrate mom on Mother's Day, others are grieving the loss of a mother or child.
The owner of Clinical Relief has said he was running a legitimate business where people with medical-marijuana cards could get pot and use it elsewhere.
Ford Motor Company is one of several metro-area companies working to keep employees healthy by taking part in an eight week weight loss challenge.
After officers responded to calls concerning two different rabid skunks, they are now alerting the neighborhood on the dangers of rabies.
Air pollution from industrial sources near Michigan public schools jeopardizes children's health and academic success, according to a new study from University of Michigan researchers.
Plymouth-based Esperion Therapeutics Monday announced the results from a Phase 1 study and four preclinical studies for its heart disease drug candidate ETC-1002. Initial results look promising.